Evaluation of clinical events and costs associated with the addition of dapagliflozin to chronic kidney disease treatment: Cost offset analysis Juan Francisco Navarro-González, Alberto Ortiz, Ana Cebrián Cuenca, Lluís Segú, Belén Pimentel, Unai Aranda, Blanca Lopez-Chicheri, Margarita Capel, Elisenda Pomares Mallol, Christian Caudron, Juan José García Sánchez, Roberto Alcázar Arroyo

The correlation between sclerostin and bone mineral density in renal transplant recipients Melahat Coban, Sarper Okten

Chronic kidney disease-mineral and bone disorder: a complex scenario Natalia Mejia, Mejía, Pablo Roman-Garcia, Roman-García, Ana Belen Miar, Miar, Beatriz Tavira, Tavira, Jorge B Cannata-Andía, Cannata-Andía